These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20537815)
21. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial. Walsh SL; Comer SD; Lofwall MR; Vince B; Levy-Cooperman N; Kelsh D; Coe MA; Jones JD; Nuzzo PA; Tiberg F; Sheldon B; Kim S JAMA Psychiatry; 2017 Sep; 74(9):894-902. PubMed ID: 28655025 [TBL] [Abstract][Full Text] [Related]
22. Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans. Bershad AK; Miller MA; Norman GJ; de Wit H Horm Behav; 2018 Jun; 102():41-47. PubMed ID: 29673620 [TBL] [Abstract][Full Text] [Related]
23. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843 [TBL] [Abstract][Full Text] [Related]
24. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Comer SD; Collins ED; Wilson ST; Donovan MR; Foltin RW; Fischman MW Eur J Pharmacol; 1998 Mar; 345(1):13-26. PubMed ID: 9593589 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Negus SS; Rice KC Neuropsychopharmacology; 2009 Mar; 34(4):899-911. PubMed ID: 18704098 [TBL] [Abstract][Full Text] [Related]
26. Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men. Sheynin J; Moustafa AA; Beck KD; Servatius RJ; Casbolt PA; Haber P; Elsayed M; Hogarth L; Myers CE J Clin Psychiatry; 2016 Mar; 77(3):386-94. PubMed ID: 27046310 [TBL] [Abstract][Full Text] [Related]
27. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. Greenwald MK Exp Clin Psychopharmacol; 2002 Feb; 10(1):39-46. PubMed ID: 11866251 [TBL] [Abstract][Full Text] [Related]
28. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers. Walsh SL; Nuzzo PA; Babalonis S; Casselton V; Lofwall MR Drug Alcohol Depend; 2016 May; 162():190-8. PubMed ID: 27012435 [TBL] [Abstract][Full Text] [Related]
29. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Comer SD; Sullivan MA; Vosburg SK; Manubay J; Amass L; Cooper ZD; Saccone P; Kleber HD Addiction; 2010 Apr; 105(4):709-18. PubMed ID: 20403021 [TBL] [Abstract][Full Text] [Related]
34. Buprenorphine: an alternative to methadone for heroin dependence treatment. Resnick RB; Galanter M; Pycha C; Cohen A; Grandison P; Flood N Psychopharmacol Bull; 1992; 28(1):109-13. PubMed ID: 1609035 [TBL] [Abstract][Full Text] [Related]
35. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure. Jones HE; Bigelow GE; Preston KL J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526 [TBL] [Abstract][Full Text] [Related]
36. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development. Negus SS; Banks ML Pharmacol Biochem Behav; 2018 Jan; 164():32-39. PubMed ID: 28442370 [TBL] [Abstract][Full Text] [Related]
37. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. Preston KL; Bigelow GE; Bickel W; Liebson IA J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262 [TBL] [Abstract][Full Text] [Related]
38. Development of buprenorphine for the treatment of opioid dependence. Johnson RE; Fudala PJ NIDA Res Monogr; 1992; 121():120-41. PubMed ID: 1383825 [TBL] [Abstract][Full Text] [Related]
39. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154 [TBL] [Abstract][Full Text] [Related]
40. Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers. Comer SD; Collins ED J Pharmacol Exp Ther; 2002 Nov; 303(2):695-703. PubMed ID: 12388653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]